glp 1 agonist medications GLP-1 Medications: Everything You Need to Know List of approved and pending

By distribution channel, the hospital pharmacies segment generated the major market share of 50% in 2025

Study Used AI to Analyze Real-World Patient Reports To better understand how people experience GLP-1 drugs outside of clinical trials, researchers used AI to analyze Reddit posts from 2019 to 2025

[DOI] [PMC free article] [PubMed] [Google Scholar] 56.Heerspink HJ, Sattar N, Pavo I, Haupt A, Duffin KL, Yang Z, et al

When to seek medical attention: Persistent vomiting preventing adequate fluid intake Severe abdominal pain, particularly if localized to the upper right quadrant (potential gallbladder issues) Severe pain in the upper abdomen radiating to the back (possible pancreatitis) Signs of dehydration (dark urine, dizziness, decreased urination) Inability to tolerate any food or liquids for more than 24 hours Severe constipation with abdominal distension or vomiting (possible ileus/obstruction) Yellowing of skin/eyes with fever and abdominal pain Patients with significant vomiting or diarrhea should be monitored for signs of acute kidney injury, particularly those with pre-existing renal impairment or taking medications that affect kidney function

Weekly injectables (semaglutide, dulaglutide) require one injection per week

The Triple Agonist Peptide Everyone's Talking About